S 81694

TTK

Paclitaxel

I/II

NCT03411161

Gedatolisb

PI3K/AKT/m-TOR

Talazoparib

I

NCT03911973

Abemaciclib

CDK4,6

II

NCT03130439

MLN0128 y MLN8237

TORC 1,2

I

NCT02719691

Aurora A

Icotinib

EGFR

II

NCT02362230

Dinaciclib

CDK 1,2,5,9

Pembrolizumab

Ib

NCT01676753

Galunisertib

TGF-β

Paclitaxel

I

NCT02672475

Bemcentinib

AXL kinase

Pembrolizumab

II

NCT03184558

M7824

TGF-β

Eribulin

I

NCT03579472

Binimetinib

MEK 1,2

Pembrolizumab

I/II

NCT03106415

Enobosarm

Receptor de andrógenos

Pembrolizumab

II

NCT02971761

L-NMMA

i-NOS

Docetaxel

I/II

NCT02834403

SGN-LIV1A

Transportador

de Zinc

Pembrolizumab

I/II

NCT03310957

Onalespib

Hsp 90

Paclitaxel

I

NCT02474173

Decitabin

DNA

metiltransferasa

Carboplatin

II

NCT03295552

AZD8186

PI3Kβ

Docetaxel

I

NCT03218826

Talazoparib

PARPi

Sacituzumab govitecan

I/II

NCT04039230

Inmunoféresis

LW-02

sTNF-R

Paclitaxel + carboplatino

I/II

NCT04004910

PMD-026

RSK1-4

I/Ib

NCT04115306

Camrelizumab

PD-1

NAB-Paclitaxel + famitinib

II

NCT04129996

LN-145

Linfocitos

infiltrantes de tumor

II

NCT04111510

Ipasertib

AKT

Atezolizumab +

NAB-Paclitaxel

III

NCT04177108

Binimetinib

ERK, CDK 4/6

Palbociclib

I/II

NCT04494958

Ipatasertib

PI3k/AKT/mTOR

Quimioterapia

IIa

NCT04464174

TTAC-0001

VGFR2

Pembrolizumab

Ib

NCT03720431

HX008

PD-1

Cisplatino + gemcitabina

I/II

NCT04750382